Improved Lung Function Is Associated With Better Asthma Control in Adolescents and Adults Aged 12 Years and Older With Moderate-To-Severe Type 2 Asthma: A Post Hoc Analysis of Quest

被引：0
|
作者：
Lipworth, B. J. [1 ]
Casale, T. B. [2 ]
Porsbjerg, C. [3 ]
Busse, W. W. [4 ]
Ellis, A. K. [5 ]
Msihid, J. [6 ]
Gall, R. [7 ]
Pandit-Abid, N. [8 ]
Wang, Z. [7 ]
Cheng, W. [9 ]
Jacob-Nara, J. A. [8 ]
Sacks, H. [7 ]
机构：
[1] Univ Dundee, Ninewells Hosp & Med Sch, Scottish Ctr Resp Res, Dundee, Scotland
[2] Univ S Florida, Morsani Coll Med, Tampa, FL USA
[3] Bispebjerg Hosp, Copenhagen, Denmark
[4] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI USA
[5] Queens Univ, Kingston, ON, Canada
[6] Sanofi, Gentilly, France
[7] Regeneron Pharmaceut Inc, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA
[8] Sanofi, Bridgewater, NJ USA
[9] Sanofi, Cambridge, MA USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2024年 / 209卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A5268
引用
收藏
页数：2
相关论文
共 27 条
  • [1] Improved lung function is associated with better asthma control in children aged 6 to 11 years with moderate-to-severe type 2 asthma: A post hoc analysis of VOYAGE
    Bacharier, L. B.
    Gerstlauer, M.
    Dell, S. D.
    de Mir, I
    Piacentini, G.
    Hamelmann, E.
    Msihid, J.
    Gall, R.
    Ledanois, O.
    Wang, Z.
    Cheng, W. -H.
    Sacks, H.
    Jacob-Nara, J. A.
    Rowe, P. J.
    Deniz, Y.
    KLINISCHE PADIATRIE, 2024, 236 (02): : S3 - S3
  • [2] Improved Lung Function is Associated With Better Asthma Control in Children Aged 6 to 11 Years With Moderate-To-Severe Type 2 Asthma: A Post Hoc Analysis of VOYAGE
    Bacharier, Leonard
    Dell, Sharon
    de Mir-Messa, Ines
    Piacentini, Giorgio
    Hamelmann, Eckard
    Msihid, Jerome
    Gall, Rebecca
    Ledanois, Olivier
    Wang, Zhixiao
    Cheng, Wei-Han
    Sacks, Harry
    Jacob-Nara, Juby
    Rowe, Paul
    Deniz, Yamo
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 153 (02) : AB99 - AB99
  • [3] Improved Lung Function Is Associated With Better Asthma Control in Children With Moderate-to-Severe Type 2 Asthma: Voyage Study
    Bacharier, L. B.
    Dell, S.
    De Mir-Messa, I.
    Piacentini, G.
    Hamelmann, E.
    Msihid, J.
    Gall, R.
    Ledanois, O.
    Wang, Z.
    Cheng, W.
    Sacks, H.
    Jacob-Nara, J. A.
    Rowe, P. J.
    Deniz, Y.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [4] Improved lung function and asthma control observed with rademikibart in patients with moderate-to-severe asthma
    Kerwin, Edward
    Guo, Jiawang
    Adivikolanu, Radha
    Longphre, Malinda
    Wang, Junying
    Yun, Jili
    Pan, Wuban
    Wei, Zheng
    Collazo, Raul
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [5] Improved lung function is associated with better asthma control in children with moderate to severe asthma with type 2 inflammation: Post-hoc results from the randomized, placebo-controlled VOYAGE trial
    Bacharier, L. B.
    Vogelberg, C.
    Dell, S.
    de Mir, I.
    Piacentini, G.
    Hamelmann, E.
    Msihid, J.
    Gall, R.
    Ledanois, O.
    Wang, Z.
    Cheng, W. - H.
    ALLERGOLOGIE, 2024, 47 (09)
  • [6] Dupilumab Improves Lung Function in Children With Moderate-to-Severe Type 2 Asthma at Week 12
    Guilbert, T. W.
    Deschildre, A.
    Murphy, K. R.
    Hamelmann, E.
    Ross, K. R.
    Gupta, A.
    Xia, C.
    Gall, R.
    Ledanois, O.
    Radwan, A.
    Jacob-Nara, J. A.
    Rowe, P. J.
    Deniz, Y.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [7] Dupilumab Improved Long-term Lung Function in Children Aged 6 to 11 Years With Moderate-to-Severe Asthma: Liberty Asthma Excursion
    Bacharier, L. B.
    Maspero, J. F.
    Katelaris, C. H.
    Fiocchi, A. G.
    Gagnon, R.
    de Mir, I.
    Guilbert, T. W.
    Jackson, D. J.
    Li, N.
    Akinlade, B.
    Laws, E.
    Mannent, L. P.
    Maloney, J.
    Tawo, K.
    Khokhar, F. A.
    Hardin, M.
    Abdulai, R. M.
    Lederer, D. J.
    Robinson, L. B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [8] EFFICACY OF DUPILUMAB IN PATIENTS WITH UNCONTROLLED, MODERATE-TO-SEVERE ASTHMA AND WITH HIGH SLEEP DISTURBANCE: A POST HOC ANALYSIS FROM LIBERTY ASTHMA QUEST
    Maspero, J.
    Shafazand, S.
    Cole, J.
    Pavord, I. D.
    Busse, W. W.
    Msihid, J.
    Gall, R.
    Soler, X.
    Siddiqui, S.
    Khan, A. H.
    Gomez, L. D. P.
    Jacob-Nara, J. A.
    VALUE IN HEALTH, 2022, 25 (07) : S550 - S550
  • [9] Dupilumab Improved Lung Function in Patients with Uncontrolled, Moderate-to-Severe Asthma Despite Exacerbation Events During the LIBERTY ASTHMA QUEST Study
    Rabe, K. F.
    Castro, M.
    Wenzel, S. E.
    Corren, J.
    Pavord, I. D.
    Katelaris, C.
    Tohda, Y.
    Rice, M. S.
    Lu, Y.
    Rowe, P.
    Staudinger, H. W.
    Amin, N.
    Akinlade, B.
    Graham, N. M. H.
    Teper, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [10] Dupilumab reduced impact of severe exacerbations on lung function in patients with moderate-to-severe type 2 asthma
    Papi, Alberto
    Corren, Jonathan
    Castro, Mario
    Domingo, Christian
    Rogers, Linda
    Chapman, Kenneth R.
    Jackson, Daniel J.
    Daizadeh, Nadia
    Pandit-Abid, Nami
    Gall, Rebecca
    Jacob-Nara, Juby A.
    Rowe, Paul J.
    Deniz, Yamo
    Ortiz, Benjamin
    ALLERGY, 2023, 78 (01) : 233 - 243
123